Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Clinical trial NCT00082966 · COMPLETED

Trial details

NCT number: NCT00082966
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Lymphocyte Depletion Hodgkin Lymphoma Adult Mixed Cellularity Hodgkin Lymphoma Adult Nodular Sclerosis Hodgkin Lymphoma Recurrent Adult Hodgkin Lymphoma

Start date: 2004-03-01
Primary completion: 2007-03-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.